NCT00652639

Bioavailability Study of Clonazepam Tablets Under Fasting Conditions

Comparative, Randomized, Single-Dose, 2 Way Cross Over Bioavailability Study of Kali's Clonazepam Tablets 1 mg With That of Klonopin Tablets 1 mg in Healthy Adult Subjects Under Fasting Conditions.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 32 (actual)
• Sponsor: Par Pharmaceutical, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

To compare the single-dose bioavailability of Clonazepam tablets 1 mg and Klonopin tablets 1 mg

Detailed description

To compare the single -dose bioavailability of kali's Clonazepam tablets 1 mg with that of Klonopin tablets 1 mg by Roche pharmaceuticals following a single oral dose under fasting conditions.

Conditions

• To Determine Bioequivalence Under Fasting Conditions

Interventions

Type	Name	Description
DRUG	Clonazepam	Tablets, 1 mg, single-dose
DRUG	Klonopin	tablets, 1 mg, single-dose

Timeline

• Start date: 2004-02-01
• Primary completion: 2004-03-01
• Completion: 2004-04-01
• First posted: 2008-04-04
• Last updated: 2008-04-04